2022
DOI: 10.1016/j.techsoc.2022.102005
|View full text |Cite
|
Sign up to set email alerts
|

Responsible intellectual property rights? Untangling open-source biotech adherence to intellectual property rights through DIYbio

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 36 publications
0
2
0
Order By: Relevance
“…Dual use is mentioned by several papers ( Getz and Dellaire, 2018 ; Torres, 2018 ; DiEuliis et al, 2019 ; Alexander Hamilton et al, 2021 ; Hagendorff, 2021 ; Grinbaum and Adomaitis, 2023 ; Vaseashta, 2023 ). However, it can have broader meaning, for example, positively referring to open source ( Esquivel-Sada, 2022 ) as opposed to negatively referring to non-conformant use. The idea of broadening the dual use research of concern (DURC) regime, which gained steam during COVID-19 ( Sandbrink et al, 2023 ) is mentioned in the preprint literature ( Grinbaum and Adomaitis, 2023 ), and alarms about dual-use involving AI are sounded in several papers ( Urbina et al, 2022 ; D’Alessandro et al, 2023 ) and in Sandbrink’s Ph.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Dual use is mentioned by several papers ( Getz and Dellaire, 2018 ; Torres, 2018 ; DiEuliis et al, 2019 ; Alexander Hamilton et al, 2021 ; Hagendorff, 2021 ; Grinbaum and Adomaitis, 2023 ; Vaseashta, 2023 ). However, it can have broader meaning, for example, positively referring to open source ( Esquivel-Sada, 2022 ) as opposed to negatively referring to non-conformant use. The idea of broadening the dual use research of concern (DURC) regime, which gained steam during COVID-19 ( Sandbrink et al, 2023 ) is mentioned in the preprint literature ( Grinbaum and Adomaitis, 2023 ), and alarms about dual-use involving AI are sounded in several papers ( Urbina et al, 2022 ; D’Alessandro et al, 2023 ) and in Sandbrink’s Ph.…”
Section: Resultsmentioning
confidence: 99%
“…Industrial challenges include: biosafety ( Pei et al, 2022 ), the availability of capital ( Baker, 2017 ; Helmy et al, 2020 ; Hodgson et al, 2022 ; Sargent et al, 2022 ), the lack of a scalable manufacturing workflow ( Hillson et al, 2019 ; Ataii et al, 2023 ), regulatory uncertainty ( Huzair, 2021 ), innovation challenges ( Banda and Huzair, 2021 ; Tait and Wield, 2021 ), intellectual property rights ( Esquivel-Sada, 2022 ), investment risks ( Hodgson et al, 2022 ), or worker safety ( Murashov et al, 2020 ).…”
Section: Discussionmentioning
confidence: 99%